Dr Reddy’s inks pact with Slayback Pharma of US to acquire rights for OTC ophthalmic product |…
HYDERABAD: Pharma major Dr Reddy’s Laboratories has entered into a licensing agreement with New Jersey-based Slayback Pharma LLC (Slayback) to acquire the rights of the latter's Brimonidine Tartrate Ophthalmic Solution0.025%, which is…